Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
They have my loyalty going forward
We generated estimates of a value-based price under two different assumptions about the long-term efficacy of GLP-1s in preventing or delaying diabetes
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 trial
The Danish researchers also documented a steep socioeconomic gradient in who gets prescribed these medications in the first place, with prescription rates nearly three times higher in the highest income quartile than the lowest
Generic and brand-name medications are therapeutically equivalent
In a type 1 diabetic Akita mouse model, which was used as a nonobese insulin-dependent model of spontaneous type 1 diabetes, empagliflozin treatment attenuated diabetes-induced rise in renal expression of markers of kidney growth by reducing the cyclin-dependent kinase inhibitors p27 and p21, which were over-expressed in early diabetic kidneys (152)
US$ 23.88
US$ 24.35
US$ 24.59
US$ 25.13
US$ 28.57
